A Versatile Plasma Membrane Engineered Cell Vehicle for Contact‐Cell‐Enhanced Photodynamic Therapy

Abstract

In this paper, a plasma membrane engineering approach is reported for tumor targeting drug delivery and contact‐cell‐enhanced photodynamic therapy (“CONCEPT”) by anchoring functionalized conjugates to cell vehicles. The membrane anchoring conjugates are comprised of a positively charged tetra‐arginine peptide sequence, a palmitic‐acid‐based membrane insertion moiety, and a lysine linker whose ε‐amine is modified with camptothecin (CPT), protoporphyrin IX (PpIX), or fluorescein (FAM). The amphipathic CPT, PpIX, or FAM conjugates (short as aCPT, aPpIX, or aFAM, respectively) can easily and steadily anchor or coanchor on the cell membrane of RAW264.7 cells (short as RCs), red blood cells, or mesenchymal stem cells. After anchoring aPpIX in RC cells, the tumor targeting ability and therapeutic effect of aPpIX‐anchored RC cells (short as aPRCs) is demonstrated in vitro and in vivo. Importantly, aPRCs exhibit the “CONCEPT” effect, which can enhance the therapeutic efficacy and reduce side effects at the single cell level. Due to the good tumor‐targeting ability, aPRCs can efficiently inhibit the tumor growth with no systemic toxicity after photoirradiation by photodynamic therapy.

Perylenediimide chromophore as an efficient photothermal agent for cancer therapy

“…injection, 5 mg kg À1 ) combined with NIR-laser irradiation (660 nm, 0.5 W cm À2 , 10 min). Nanoparticles can permeate into tumor sites, owing to their enhanced permeability and retention (EPR) effect [7,[37][38][39][40]. Twenty-four hour postinjection of the PDI-NPs, NIR laser irradiation of the whole tumor region was carried out.…”

Recent Advances in Subcellular Targeted Cancer Therapy Based on Functional Materials

“…All of these flaws will hamper the ROS generation and cause severe side effects, resulting in unsatisfied PDT outcome. To date, a myriad of strategies based on functional‐PS conjugates or PS‐delivery nanoplatforms have been developed to solve the above concerns for improved PDT effect by damaging specific subcellular structures, which provide a new insight into precise PDT with much higher efficiency.…”

Recent Advances in Targeted Tumor Chemotherapy Based on Smart Nanomedicines

“…Thus, homotypic targeting strategy could offer specific targeting to certain tumors through changing the cell membrane source. So far, various CCMs from HeLa cell, MCF‐7 cell, murine mammary carcinoma (4T1) cell, and RAW264.7 cell have been extracted to camouflage nanomedicines. This established approach also circumvent the complications of identifying and constructing the synthetic ligands.…”